We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+22.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$68.5B
AUM Growth
+$9.41B
Cap. Flow
-$1.48B
Cap. Flow %
-2.16%
Top 10 Hldgs %
11.5%
Holding
2,417
New
97
Increased
651
Reduced
820
Closed
64

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$694M
2
BNY
Bank of New York Mellon
BNY
+$668M
3
MRSH
Marsh
MRSH
+$609M
4
DIS icon
Walt Disney
DIS
+$140M
5
TFC icon
Truist Financial
TFC
+$128M

Sector Composition

Rank Sector Weight
1 Technology 18.62%
2 Healthcare 15.47%
3 Financials 13.03%
4 Industrials 11.38%
5 Consumer Discretionary 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROIC
951
DELISTED
Retail Opportunity Investments Corp.
ROIC
$3.2M ﹤0.01%
238,767
+203,591
+579% +$2.49M
SBRA icon
952
Sabra Healthcare REIT
SBRA
$5.61B
$3.2M ﹤0.01%
183,971
-175,103
-49% -$2.79M
KLAC icon
953
KLA
KLAC
$249B
$3.19M ﹤0.01%
123,310
-11,350
-8% -$265K
CYBR
954
DELISTED
CyberArk
CYBR
$3.17M ﹤0.01%
19,649
-1,539
-7% -$179K
OKE icon
955
Oneok
OKE
$55.9B
$3.17M ﹤0.01%
82,552
+4,775
+6% +$161K
EPR icon
956
EPR Properties
EPR
$4.92B
$3.15M ﹤0.01%
96,826
-12,801
-12% -$377K
MGM icon
957
MGM Resorts International
MGM
$11.8B
$3.11M ﹤0.01%
98,653
+81,427
+473% +$2.1M
BAP icon
958
Credicorp
BAP
$30.9B
$3.08M ﹤0.01%
18,750
+2,706
+17% +$375K
WY icon
959
Weyerhaeuser
WY
$17.7B
$3.07M ﹤0.01%
91,524
-3,021
-3% -$90.9K
AMED
960
DELISTED
Amedisys
AMED
$3.02M ﹤0.01%
10,281
-646
-6% -$166K
WBA
961
DELISTED
Walgreens Boots Alliance
WBA
$3M ﹤0.01%
75,308
-22,400
-23% -$868K
ACC
962
DELISTED
American Campus Communities, Inc.
ACC
$3M ﹤0.01%
70,127
+25,474
+57% +$1.02M
NMRK icon
963
Newmark Group
NMRK
$2.88B
$2.99M ﹤0.01%
410,688
+403,800
+5,862% +$2.5M
FRPT icon
964
Freshpet
FRPT
$3.01B
$2.99M ﹤0.01%
21,063
-6,425
-23% -$829K
GNRC icon
965
Generac Holdings
GNRC
$11.5B
$2.98M ﹤0.01%
13,111
-70
-0.5% -$15.1K
CNA icon
966
CNA Financial
CNA
$15B
$2.98M ﹤0.01%
76,437
+16,237
+27% +$553K
FHN icon
967
First Horizon
FHN
$12.3B
$2.98M ﹤0.01%
233,201
+18,809
+9% +$220K
ZNGA
968
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$2.96M ﹤0.01%
299,510
-17,173
-5% -$155K
APLE icon
969
Apple Hospitality REIT
APLE
$3.97B
$2.94M ﹤0.01%
227,937
+90,693
+66% +$1.08M
DNLI icon
970
Denali Therapeutics
DNLI
$3.82B
$2.92M ﹤0.01%
34,841
+31,030
+814% +$1.88M
APH icon
971
Amphenol
APH
$177B
$2.9M ﹤0.01%
88,760
-12,500
-12% -$384K
PLMR icon
972
Palomar
PLMR
$3.79B
$2.89M ﹤0.01%
32,508
+565
+2% +$47.5K
BG icon
973
Bunge Global
BG
$22.8B
$2.88M ﹤0.01%
43,880
-4,753
-10% -$277K
EMBJ
974
Embraer S.A. ADS
EMBJ
$12.3B
$2.87M ﹤0.01%
420,704
LNT icon
975
Alliant Energy
LNT
$19.1B
$2.86M ﹤0.01%
55,478
-130,548
-70% -$7.02M

Similar funds

Macquarie Group's Q4 2020 Portfolio in Review

As of Q4 2020, Macquarie Group held 2,417 positions worth $68.5B, up 16% from $59.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group's Q4 2020 filing shows 97 new, 651 increased, 820 reduced and 64 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M. The largest sale was Pfizer, an estimated $694M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Macquarie Group's largest Q4 2020 buy was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M.
  • Macquarie Group added most to Discover Financial Services in Q4 2020, an estimated $613M increase.
  • Macquarie Group's biggest Q4 2020 reduction was Pfizer, cutting an estimated $694M.
  • Macquarie Group fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $64.8M.
  • Macquarie Group's ten largest holdings make up 11% of its $68.5B portfolio in Q4 2020.
  • Macquarie Group opened 97 new positions and closed 64 in Q4 2020.
  • Macquarie Group's portfolio value rose 16% quarter-over-quarter to $68.5B.

Based on Macquarie Group's 13F filing for Q4 2020, filed 16 Feb 2021.